Aquilo Capital Management, LLC

Investment Portfolio & 13F Holdings Analysis

About
CIK: 0001591986
Type: FundHoldings: 13Value: $55.8MLatest: 2025Q1

Aquilo Capital Management, LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 13 holdings worth $0.1 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
13
Total Value
55776888
Accession Number
0001591986-25-000004
Form Type
13F-HR
Manager Name
Aquilo-Capital-Management
Data Enrichment
100% identified
13 identified0 unidentified

Holdings

13 positions
Manager:
Search and click to pin securities to the top
AMGEN INC
Shares:60.0K
Value:$18.7M
Blueprint Medicines Corp
Shares:83.9K
Value:$7.4M
ARROWHEAD PHARMACEUTICALS, INC.
Shares:550.1K
Value:$7.0M
Protagonist Therapeutics, Inc
Shares:81.7K
Value:$4.0M
Kymera Therapeutics, Inc.
Shares:138.5K
Value:$3.8M
PRECISION BIOSCIENCES INC
Shares:726.1K
Value:$3.5M
ARVINAS, INC.
Shares:360.8K
Value:$2.5M
REGENXBIO Inc.
Shares:271.3K
Value:$1.9M
Adicet Bio, Inc.
Shares:2.5M
Value:$1.9M
BICYCLE THERAPEUTICS PLC
Shares:171.7K
Value:$1.5M
Immatics N.V.
Shares:304.9K
Value:$1.4M
Repare Therapeutics Inc.
Shares:1.3M
Value:$1.3M
Zymeworks Inc.
Shares:84.5K
Value:$1.0M